Iq Eq Fund Management (Ireland) LTD Gilead Sciences, Inc. Transaction History

Iq Eq Fund Management (Ireland) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$63.47 - $69.35 $365,841 - $399,733	-5,764 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $58,560 - $66,816	976 Added 20.38%	5,764 $373,000
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $80,542 - $103,162	-1,286 Reduced 21.17%	4,788 $358,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $24,734 - $27,385	-347 Reduced 5.4%	6,074 $489,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $416,594 - $485,941	6,421 New	6,421 $515,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.